David Lewis
Stock Analyst at Morgan Stanley
(1.79)
# 1,980
Out of 4,482 analysts
134
Total ratings
68.09%
Success rate
11.03%
Average return
Main Sectors:
27 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Equal-Weight | $112 → $107 | $102.33 | +4.56% | 10 | Oct 19, 2023 | |
| NTLA Intellia Therapeutics | Maintains: Neutral | $44 → $40 | $22.95 | +74.29% | 2 | Aug 4, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $273 → $300 | $196.72 | +52.50% | 7 | Nov 4, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $272 → $275 | $228.84 | +20.17% | 9 | Oct 11, 2022 | |
| NVRO Nevro | Maintains: Equal-Weight | $55 → $54 | $8.38 | +544.39% | 7 | Aug 4, 2022 | |
| DXCM DexCom | Maintains: Equal-Weight | $91 → $91 | $110.91 | -17.95% | 13 | Jun 15, 2022 | |
| OM Outset Medical | Maintains: Overweight | $50 → $48 | $3.84 | +1,150.00% | 2 | May 5, 2022 | |
| BAX Baxter International | Maintains: Overweight | $105 → $100 | $33.16 | +201.57% | 10 | Apr 29, 2022 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $22 → $15 | $149.53 | -89.97% | 3 | Feb 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $37 → $30 | $6.30 | +376.19% | 3 | Feb 25, 2022 | |
| AXNX Axonics | Maintains: Overweight | $73 → $69 | $67.52 | +2.19% | 3 | Feb 25, 2022 | |
| HOLX Hologic | Maintains: Equal-Weight | $76 → $75 | $73.48 | +2.07% | 3 | Feb 3, 2022 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $42 → $45 | $16.29 | +176.24% | 2 | Jan 7, 2022 | |
| HAE Haemonetics | Maintains: Equal-Weight | $68 → $60 | $84.13 | -28.68% | 9 | Jan 7, 2022 | |
| GMED Globus Medical | Maintains: Equal-Weight | $80 → $82 | $68.62 | +19.50% | 3 | Jan 7, 2022 | |
| MDT Medtronic | Maintains: Overweight | n/a | $77.17 | - | 10 | Aug 25, 2021 | |
| IRTC iRhythm Technologies | Downgrades: Equal-Weight | n/a | $96.76 | - | 2 | Apr 14, 2021 | |
| SIBN SI-BONE | Maintains: Overweight | n/a | $13.04 | - | 2 | Mar 9, 2021 | |
| BVS Bioventus | Initiates: Overweight | n/a | $5.89 | - | 1 | Mar 8, 2021 | |
| ALC Alcon | Maintains: Overweight | n/a | $88.13 | - | 3 | Feb 25, 2021 | |
| ZBH Zimmer Biomet Holdings | Maintains: Overweight | n/a | $106.58 | - | 9 | Feb 8, 2021 | |
| SYK Stryker | Maintains: Overweight | n/a | $332.02 | - | 2 | Jan 28, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Equal-Weight | n/a | $434.81 | - | 8 | Dec 15, 2020 | |
| EW Edwards Lifesciences | Maintains: Overweight | n/a | $91.08 | - | 2 | Apr 24, 2020 | |
| TFX Teleflex | Maintains: Overweight | n/a | $211.44 | - | 1 | Mar 27, 2020 | |
| JNJ Johnson & Johnson | Maintains: Overweight | n/a | $145.69 | - | 7 | Mar 27, 2020 | |
| AVNS Avanos Medical | Maintains: Underweight | n/a | $19.42 | - | 1 | Mar 27, 2020 |
Abbott Laboratories
Oct 19, 2023
Maintains: Equal-Weight
Price Target: $112 → $107
Current: $102.33
Upside: +4.56%
Intellia Therapeutics
Aug 4, 2023
Maintains: Neutral
Price Target: $44 → $40
Current: $22.95
Upside: +74.29%
Insulet
Nov 4, 2022
Maintains: Equal-Weight
Price Target: $273 → $300
Current: $196.72
Upside: +52.50%
Becton, Dickinson and Company
Oct 11, 2022
Maintains: Overweight
Price Target: $272 → $275
Current: $228.84
Upside: +20.17%
Nevro
Aug 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $54
Current: $8.38
Upside: +544.39%
DexCom
Jun 15, 2022
Maintains: Equal-Weight
Price Target: $91 → $91
Current: $110.91
Upside: -17.95%
Outset Medical
May 5, 2022
Maintains: Overweight
Price Target: $50 → $48
Current: $3.84
Upside: +1,150.00%
Baxter International
Apr 29, 2022
Maintains: Overweight
Price Target: $105 → $100
Current: $33.16
Upside: +201.57%
TransMedics Group
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $22 → $15
Current: $149.53
Upside: -89.97%
Pulmonx
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $37 → $30
Current: $6.30
Upside: +376.19%
Axonics
Feb 25, 2022
Maintains: Overweight
Price Target: $73 → $69
Current: $67.52
Upside: +2.19%
Hologic
Feb 3, 2022
Maintains: Equal-Weight
Price Target: $76 → $75
Current: $73.48
Upside: +2.07%
Envista Holdings
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $42 → $45
Current: $16.29
Upside: +176.24%
Haemonetics
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $68 → $60
Current: $84.13
Upside: -28.68%
Globus Medical
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $80 → $82
Current: $68.62
Upside: +19.50%
Medtronic
Aug 25, 2021
Maintains: Overweight
Price Target: n/a
Current: $77.17
Upside: -
iRhythm Technologies
Apr 14, 2021
Downgrades: Equal-Weight
Price Target: n/a
Current: $96.76
Upside: -
SI-BONE
Mar 9, 2021
Maintains: Overweight
Price Target: n/a
Current: $13.04
Upside: -
Bioventus
Mar 8, 2021
Initiates: Overweight
Price Target: n/a
Current: $5.89
Upside: -
Alcon
Feb 25, 2021
Maintains: Overweight
Price Target: n/a
Current: $88.13
Upside: -
Zimmer Biomet Holdings
Feb 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $106.58
Upside: -
Stryker
Jan 28, 2021
Maintains: Overweight
Price Target: n/a
Current: $332.02
Upside: -
Intuitive Surgical
Dec 15, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $434.81
Upside: -
Edwards Lifesciences
Apr 24, 2020
Maintains: Overweight
Price Target: n/a
Current: $91.08
Upside: -
Teleflex
Mar 27, 2020
Maintains: Overweight
Price Target: n/a
Current: $211.44
Upside: -
Johnson & Johnson
Mar 27, 2020
Maintains: Overweight
Price Target: n/a
Current: $145.69
Upside: -
Avanos Medical
Mar 27, 2020
Maintains: Underweight
Price Target: n/a
Current: $19.42
Upside: -